Thiopentone induced enhancement of somatic motor responses to noxious stimulation: Influence of GABAA receptor modulation

Canadian Journal of Anesthesia

Volumn 43, Issue 5, 1996, Pages 503-510

  Archer, David P ^a,b   Ewen, Alastair ^a   Froelich, Jennifer ^a   Roth, Sheldon H ^a   Samanani, Naaznin ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

Anaesthetics, intravenous: thiopentone; Pain: antianalgesia; Receptors: GABAA

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BICUCULLINE; MUSCIMOL; THIOPENTAL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPERALGESIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BICUCULLINE; GABA MODULATORS; HYPNOTICS AND SEDATIVES; MALE; MUSCIMOL; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; THIOPENTAL;

EID: 0029895403     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03018113     Document Type: Article

References (31)

1. Dundee JW. Alterations in responses to somatic pain associated with anaesthesia. II. The effect of thiopentone and penobarbitone. Br J Anaesth 1960; 32: 407-14.
2. Cleland CL, Lim F-Y, Gebhart GF. Pentobarbital prevents the development of C-fiber-induced hyperalgesia in the rat. Pain 1994; 57: 31-43.
3. Collins JG, Ren K. WDR response profiles of spinal dorsal horn neurons may be unmasked by barbiturate anesthesia. Pain 1987; 28: 369-78.
4. Hori Y, Lee KH, Chung JM, Endo K, Willis WD. The effects of small doses of barbiturate on the activity of primate nociceptive tract cells. Brain Res 1984; 307: 9-15.
5. Neal MJ. The hyperalgesic action of barbiturates in mice. Br J Pharmacol 1965; 24: 170-7.
6. Sandkühler J, Gebhart GF. Characterization of inhibition of a spinal nociceptive reflex by stimulation medially and laterally in the midbrain and medulla in the pentobarbitalanesthetized rat. Brain Res 1984; 305:67-76.
7. Stein C, Morgan MM, Liebeskind JC. Barbiturate-induced inhibition of a spinal nociceptive reflex: role of GABA mechanisms and descending modulation. Brain Res 1987; 407: 307-11.
8. Tomemori N, Shingu K, Komatsu N, Urabe N, Mori K. Antianalgesic action of thiamylal sodium in cats. Acta Anaesth Scand 1981; 25: 523-5.
9. Jewett BA, Gibbs LM, Tarasiuk A, Kendig JJ. Propofol and barbiturate depression of spinal nociceptive neurotransmission. Anesthesiology 1992; 77: 1148-54.
10. Sandkühler J, Fu Q-C, Helmchen C, Zimmerman M. Pentobarbital, in subanesthetic doses, depresses spinal transmission of nociceptive information but does not affect stimulation-produced descending inhibition in the cat. Pain 1987; 31: 381-90.
11. Kitihata LM, Saberski L. Are barbiturates hyperalgesic? (Editorial). Anesthesiology 1992; 77: 1059-61.
12. Kissin I, Mason JO III, Bradley EL Jr. Morphine and fentanyl hypnotic interactions with thiopental. Anesthesiology 1987; 67: 331-5.
13. Kissin I, Mason JO III, Bradley EL Jr. Morphine and fentanyl interactions with thiopental in relation to movement response to noxious stimulation. Anesth Analg 1986; 65: 1149-54.
14. Archer DP, Ewen A, Roth SH, Samarani N. Plasma, brain, and spinal cord concentrations of thiopental associated with hyperalgesia in the rat. Anesthesiology 1994; 80: 168-76.
15. Ewen A, Archer DP, Samanani N, Roth SH. Hyperalgesia during sedation: effects of barbiturates and propofol in the rat. Can J Anaesth 1995; 42: 532-40.
16. Hugo S, Lake APJ, Cooledge BA. Are barbiturates hyperalgesic? (Editorial). Anesthesiology 1994; 80: 1413-4.
17. A receptor/chloride channel complex in anesthesia. Anesthesiology 1993; 78: 757-76.
18. Fields HL, Heinricher MM. Anatomy and physiology of a nociceptive modulatory system. Philos Trans Royal Soc Lond B Biol Sci 1985; 308: 361-74.
19. Kelly PAT, McCulloch J. Effects of the putative GABAergic agonists, muscimol and THIP, upon local cerebral glucose utilisation. J Neurochem 1982; 39: 613-24.
20. Baraldi M, Grandison L, Guidotti A. Distribution and metabolism of muscimol in the brain and other tissues of the rat. Neuropharmacology 1979; 18: 57-62.
21. B receptor agonists evoked vagal nerve efferent transmission in the rat. Jpn J Pharmacol 1991; 55: 11-8.
22. Soncrant TT, Holloway HW, Stipetic M, Rapoport SI. Cerebral glucose utilization is not altered by hindlimb restraint or by femoral artery and vein cannulation. J Cereb Blood Flow Metab 1988; 8: 720-6.
23. Randall LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmcodyn Ther 1957; 111: 409-19.
24. Drawer EJ, Hammond DL. GABAergic modulation of nociceptive threshold: effects of THIP and bicuculline microinjected in the ventral medulla of the rat. Brain Res 1988; 450: 316-24.
25. Moreau J-L, Fields HL. Evidence for GABA involvement in midbrain control of medullary neurons that modulate nociceptive transmission. Brain Res 1986; 397: 37-46.
26. Attal N, Chen YL, Kayser V, Guilbaud G. Behavioural evidence that systemic morphine may modulate a phasic pain-related behavior in a rat model of peripheral mononeuropathy. Pain 1991; 47: 65-70.
27. Levesque D, Holtzman SG. The potentiating effects of restraint stress and continuous naloxone infusion on the analgesic potency of morphine are additive. Brain Res 1993; 617: 176-80.
28. Kissin I, Brown PT, Robinson C, Bradley EL Jr. Acute tolerance in morphine analgesia: continuous infusion and single injection in rats. Anesthesiology 1991; 74: 166-71.
29. Andree T, Kendall DA, Enna SJ. THIP analgesia: cross tolerance with morphine. Life Sci 1983; 32: 2265-72.
30. Kendall DA, Browner M, Enna SJ. Comparison of the antinociceptive effect of -aminobutyric acid (GABA) agonists: evidence for a cholinergic involvement. J Pharmacol Exp Ther 1982; 220: 482-7.
31. Sawynok J. GAB Aergic mechanisms of analgesia: an update. Pharmacol Biochem Behav 1987; 26: 463-74.